** Shares of major U.S. drugmakers rise between 2% and 3% in early trading amid a broader market selloff
** Johnson & Johnson JNJ.N rises 2.4% to $159.07, Merck MRK.N 2.2% to $88.33, AbbVie ABBV.N 2.5% to $210.28, Amgen AMGN.O 2.3% to $312.23
** The pharma sector ducked U.S. President Donald Trump's sweeping tariffs announced on Wednesday for now
** The news came as "a big positive to the (pharma) sector that has been under pressure from this for the last two weeks," UBS analysts said, adding that AbbVie and Merck, with significant ex-U.S. manufacturing, came out as "big winners"
** However, the administration's call for "robust and resilient domestic manufacturing" in the sector, suggests that it remained on its radar - UBS
** Up to last close, JNJ up 7.4%, AMGN up 17.3%, MRK down ~13%, ABBV up 15.5% so far this year
(Reporting by Mariam Sunny in Bengaluru)
((Mariam.ESunny@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。